Literature DB >> 26216819

Minimally Invasive Retroperitoneal Lymphadenectomy: Current Status.

Thomas Kunit1, Günter Janetschek2.   

Abstract

Although the standard approach of retroperitoneal lymphadnectomy (RLA) is open surgery, laparoscopy is an emerging technique in urology and reports of laparoscopic RLA are increasing. This article presents the indications, technique, and outcome of RLA as primary treatment and post-cisplatin-based chemotherapy by means of laparoscopy. In expert hands RLA is minimally invasive and reduces morbidity in comparison with open surgery, with the same oncologic outcome. However, patient selection is crucial.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dissection; Laparoscopy; Lymph node; RPLND; Retroperitoneal; Testicular cancer

Mesh:

Year:  2015        PMID: 26216819     DOI: 10.1016/j.ucl.2015.04.006

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  3 in total

Review 1.  Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma.

Authors:  Brian Hu; Siamak Daneshmand
Journal:  Adv Urol       Date:  2018-02-01

2.  Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study.

Authors:  K-P Dieckmann; P Anheuser; M Kulejewski; R Gehrckens; B Feyerabend
Journal:  BMC Urol       Date:  2018-10-26       Impact factor: 2.264

Review 3.  Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature.

Authors:  Christian Guido Ruf; Simon Krampe; Cord Matthies; Petra Anheuser; Tim Nestler; Jörg Simon; Hendrik Isbarn; Klaus Peter Dieckmann
Journal:  World J Surg Oncol       Date:  2020-09-24       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.